PLoS ONE (Jan 2017)

HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/β-catenin pathway.

  • Zheying Zhang,
  • Yaya Chang,
  • Jianming Zhang,
  • Yanxia Lu,
  • Lin Zheng,
  • Yuhan Hu,
  • Fan Zhang,
  • Xiaomin Li,
  • Wenjuan Zhang,
  • Xuenong Li

DOI
https://doi.org/10.1371/journal.pone.0179741
Journal volume & issue
Vol. 12, no. 7
p. e0179741

Abstract

Read online

Colorectal cancer (CRC) is the third leading cause of cancer-related deaths and a major health problem. High mobility group box 3 (HMGB3), a member of the high-mobility group box (HMGB) family, was reported to be over-expressed in gastric carcinoma and bladder cancer. However, the function of HMGB3 in CRC remains unclear. Here, we found that HMGB3 was up-regulated in CRC at both mRNA and protein levels. qRT-PCR results showed that high expression of HMGB3 had positive correlation with serosal invasion, lymph metastasis, and tumor-node-metastasis (TNM) stage in CRC patient. Functional experiments showed that HMGB3 can promote CRC cells proliferation and migration in vitro. Moreover, we found HMGB3 can active WNT/β-catenin pathway to increase the expression level of c-Myc and MMP7. These results may be the reason for HMGB3 oncogene role in CRC. In summary, our data indicated that HMGB3 may serve as an oncoprotein and could be used as a potential prognostic marker in CRC.